Matthew During

Person

Columbus, OH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for treatment of epileptic disorders
- Patent number 12,144,801
- Issue date Nov 19, 2024
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treatment of epileptic disorders
- Patent number 12,109,201
- Issue date Oct 8, 2024
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating seizure disorders and Prader-Willi syndrome
- Patent number 11,918,551
- Issue date Mar 5, 2024
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treatment of epileptic disorders
- Patent number 11,918,563
- Issue date Mar 5, 2024
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treatment of epileptic disorders
- Patent number 11,903,930
- Issue date Feb 20, 2024
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treatment of epileptic disorders
- Patent number 11,806,336
- Issue date Nov 7, 2023
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carbo...
- Patent number 11,771,671
- Issue date Oct 3, 2023
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of MIR101 or MIR128 in the treatment of seizure disorders
- Patent number 11,761,006
- Issue date Sep 19, 2023
- OVID THERAPEUTICS INC
- Matthew During
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
- Patent number 11,690,829
- Issue date Jul 4, 2023
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxy...
- Patent number 11,660,277
- Issue date May 30, 2023
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treatment of epileptic disorders
- Patent number 11,395,817
- Issue date Jul 26, 2022
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gaboxadol for therapeutic treatment of 1p36 deletion syndrome
- Patent number 11,364,228
- Issue date Jun 21, 2022
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of gaboxadol in the treatment of diabetes and related conditions
- Patent number 11,291,658
- Issue date Apr 5, 2022
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating aggression associated with Alzheimer's disease
- Patent number 11,278,529
- Issue date Mar 22, 2022
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome
- Patent number 11,130,952
- Issue date Sep 28, 2021
- OVID THERAPEUTICS INC
- Matthew During
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating developmental disorders with gaboxadol
- Patent number 11,096,929
- Issue date Aug 24, 2021
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of gaboxadol for the treatment of Tourette syndrome, tics and s...
- Patent number 11,090,293
- Issue date Aug 17, 2021
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating developmental disorders and/or seizure disorder...
- Patent number 10,925,879
- Issue date Feb 23, 2021
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of MIR101 or MIR128 in the treatment of seizure disorders
- Patent number 10,870,855
- Issue date Dec 22, 2020
- OVID THERAPEUTICS INC
- Matthew During
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of MIR101 or MIR128 in the treatment of seizure disorders
- Patent number 10,837,017
- Issue date Nov 17, 2020
- OVID THERAPEUTICS INC
- Matthew During
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of Gaboxadol in the treatment of diabetes and related conditions
- Patent number 10,813,918
- Issue date Oct 27, 2020
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxy...
- Patent number 10,813,899
- Issue date Oct 27, 2020
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treatment of epileptic disorders
- Patent number 10,799,485
- Issue date Oct 13, 2020
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of gaboxadol for the treatment of Tourette syndrome, tics and s...
- Patent number 10,765,666
- Issue date Sep 8, 2020
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating developmental encephalopathies
- Patent number 10,765,646
- Issue date Sep 8, 2020
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating developmental syndromes with PDE10A inhibitors
- Patent number 10,736,894
- Issue date Aug 11, 2020
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome
- Patent number 10,704,048
- Issue date Jul 7, 2020
- OVID THERAPEUTICS INC
- Matthew During
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carbo...
- Patent number 10,653,652
- Issue date May 19, 2020
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treatment of epileptic disorders
- Patent number 10,603,308
- Issue date Mar 31, 2020
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating behavioral syndromes using pipradrol
- Patent number 10,493,069
- Issue date Dec 3, 2019
- OVID THERAPEUTICS INC
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TR...
- Publication number 20240252447
- Publication date Aug 1, 2024
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME
- Publication number 20240173280
- Publication date May 30, 2024
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
- Publication number 20240066011
- Publication date Feb 29, 2024
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBO...
- Publication number 20230404955
- Publication date Dec 21, 2023
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AAV-VECTORS FOR USE IN GENE THERAPY OF CHOROIDEREMIA
- Publication number 20230332176
- Publication date Oct 19, 2023
- Oxford University Innovation Limited
- Robert E. Maclaren
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
- Publication number 20230293502
- Publication date Sep 21, 2023
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
- Publication number 20230293501
- Publication date Sep 21, 2023
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF GABOXADOL FOR THE TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER
- Publication number 20230285369
- Publication date Sep 14, 2023
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXY...
- Publication number 20230255914
- Publication date Aug 17, 2023
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME
- Publication number 20230149332
- Publication date May 18, 2023
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
- Publication number 20230071127
- Publication date Mar 9, 2023
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA
- Publication number 20230051859
- Publication date Feb 16, 2023
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
- Publication number 20220362224
- Publication date Nov 17, 2022
- Ovid Therapeutics, Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
- Publication number 20220323424
- Publication date Oct 13, 2022
- Ovid Therapeutics, Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS
- Publication number 20220241253
- Publication date Aug 4, 2022
- Ovid Therapeutics, Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT...
- Publication number 20220110917
- Publication date Apr 14, 2022
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TR...
- Publication number 20220040120
- Publication date Feb 10, 2022
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA
- Publication number 20220016091
- Publication date Jan 20, 2022
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF DEPRESSIVE DISORDERS
- Publication number 20210379028
- Publication date Dec 9, 2021
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT ADENO-ASSOCIATED VECTORS
- Publication number 20210371880
- Publication date Dec 2, 2021
- Ovid Therapeutics Inc.
- Matthew DURING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
- Publication number 20210283075
- Publication date Sep 16, 2021
- Ovid Therapeutics, Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
- Publication number 20210213000
- Publication date Jul 15, 2021
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME
- Publication number 20210186938
- Publication date Jun 24, 2021
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF GABOXADOL IN THE TREATMENT OF GASTROINTESTINAL TRACT DISORDE...
- Publication number 20210177805
- Publication date Jun 17, 2021
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXY...
- Publication number 20210100763
- Publication date Apr 8, 2021
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF MIR101 OR MIR128 IN THE TREATMENT OF SEIZURE DISORDERS
- Publication number 20210095292
- Publication date Apr 1, 2021
- Ovid Therapeutics Inc.
- Matthew DURING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AAV-VECTORS FOR USE IN GENE THERAPY OF CHOROIDEREMIA
- Publication number 20210032656
- Publication date Feb 4, 2021
- Oxford University Innovation Limited
- Robert MACLAREN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
- Publication number 20210030727
- Publication date Feb 4, 2021
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF GABOXADOL IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS
- Publication number 20210030728
- Publication date Feb 4, 2021
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TR...
- Publication number 20210015760
- Publication date Jan 21, 2021
- Ovid Therapeutics Inc.
- Matthew During
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Matthew During

Person

Patents Grantslast 30 patents

Methods and compositions for treatment of epileptic disorders

Methods and compositions for treatment of epileptic disorders

Methods of treating seizure disorders and Prader-Willi syndrome

Methods and compositions for treatment of epileptic disorders

Methods and compositions for treatment of epileptic disorders

Methods and compositions for treatment of epileptic disorders

Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carbo...

Use of MIR101 or MIR128 in the treatment of seizure disorders

Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder

Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxy...

Methods and compositions for treatment of epileptic disorders

Gaboxadol for therapeutic treatment of 1p36 deletion syndrome

Use of gaboxadol in the treatment of diabetes and related conditions

Methods for treating aggression associated with Alzheimer's disease

Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome

Methods of treating developmental disorders with gaboxadol

Use of gaboxadol for the treatment of Tourette syndrome, tics and s...

Methods of treating developmental disorders and/or seizure disorder...

Use of MIR101 or MIR128 in the treatment of seizure disorders

Use of MIR101 or MIR128 in the treatment of seizure disorders

Use of Gaboxadol in the treatment of diabetes and related conditions

Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxy...

Methods and compositions for treatment of epileptic disorders

Use of gaboxadol for the treatment of Tourette syndrome, tics and s...

Methods of treating developmental encephalopathies

Methods of treating developmental syndromes with PDE10A inhibitors

Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome

Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carbo...

Methods and compositions for treatment of epileptic disorders

Methods of treating behavioral syndromes using pipradrol

Patents Applicationslast 30 patents

PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TR...

METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBO...

AAV-VECTORS FOR USE IN GENE THERAPY OF CHOROIDEREMIA

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

USE OF GABOXADOL FOR THE TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER

USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXY...

METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME

METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL

METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS

USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT...

PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TR...

METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA

TREATMENT OF DEPRESSIVE DISORDERS

RECOMBINANT ADENO-ASSOCIATED VECTORS

METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME

USE OF GABOXADOL IN THE TREATMENT OF GASTROINTESTINAL TRACT DISORDE...

USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXY...

USE OF MIR101 OR MIR128 IN THE TREATMENT OF SEIZURE DISORDERS

AAV-VECTORS FOR USE IN GENE THERAPY OF CHOROIDEREMIA

METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL

USE OF GABOXADOL IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS

PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TR...